Biocytin hydrazide

What We Offer

Biocytin hydrazide

Biocytin hydrazide | CAS 102743-85-1

Catalog Number A16-0070
Category Cell Proliferation Tracer Fluorescent Probes
Molecular Formula C16H30N6O3S
Molecular Weight 386.51
Inquiry

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Product Introduction

Biocytin hydrazide is a biotin derivative that features a hydrazide functional group, enabling its conjugation to aldehyde or ketone groups through the formation of stable hydrazone bonds. This compound participates in fluorescence labeling workflows as a biotinylation reagent, facilitating the detection and quantification of biomolecules when used in conjunction with fluorescently labeled avidin or streptavidin. Biocytin hydrazide is incorporated into research applications involving protein labeling, cell surface labeling, and affinity purification, supporting diverse biochemical and bioimaging studies.

  • Chemical Information

  • Product Specification

  • Application

  • Computed Properties

  • Patents

Chemical Information

Synonyms 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[(5S)-5-amino-6-hydrazinyl-6-oxohexyl]pentanamide
IUPAC Name 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[(5S)-5-amino-6-hydrazinyl-6-oxohexyl]pentanamide
SMILES C1C2C(C(S1)CCCCC(=O)NCCCCC(C(=O)NN)N)NC(=O)N2
InChI InChI=1S/C16H30N6O3S/c17-10(15(24)22-18)5-3-4-8-19-13(23)7-2-1-6-12-14-11(9-26-12)20-16(25)21-14/h10-12,14H,1-9,17-18H2,(H,19,23)(H,22,24)(H2,20,21,25)/t10-,11-,12-,14-/m0/s1
InChIKey XSXHTPJCSHZYFJ-MNXVOIDGSA-N
Appearance Solid Powder

Product Specification

Excitation 546
Emission 565
Signal Warning
GHSHazardStatements H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Precautionary Statement Codes P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (The corresponding statement to each P-code can be found at the GHS Classification page.)

Application

Computed Properties

XLogP3 -1.2
Hydrogen Bond Donor Count 6
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 11
Exact Mass 386.21001001 g/mol
Monoisotopic Mass 386.21001001 g/mol
Topological Polar Surface Area 177Ų
Heavy Atom Count 26
Formal Charge 0
Complexity 506
Isotope Atom Count 0
Defined Atom Stereocenter Count 4
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Patents

Publication Number Title Priority Date
CN-113980966-A Nucleic acid sequence for inhibiting PCSK9 target gene expression and application thereof 2021-09-29
US-2022283179-A1 Methods and compositions for detecting protein targets 2021-03-02
WO-2022187342-A1 Methods and compositions for detecting protein targets 2021-03-02
US-2020323961-A1 Lipid-based nanoparticles and use of same in optimized insulin dosing regimens 2019-04-12
WO-2020210697-A1 Lipid-based nanoparticles and use of same in optimized insulin dosing regimens 2019-04-12

Recommended Services

Recommended Articles

Recommended Products

Online Inquiry

Verification code
cartIcon
Inquiry Basket